Antiinflammatory activities of 2-acetyl- and 2-(1-hydroxyethyl)-4-(3-(dimethylamino)propyl)-3,4-dihydro-3-phenyl-2H-1,4-benzothiazine.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D001168:Arthritis / Q000188:drug therapy; D001183:Arthus Reaction / Q000188:drug therapy; D002462:Cell Membrane / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D004285:Dogs; D004487:Edema / Q000188:drug therapy; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006386:Hemagglutination Tests; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008744:Methylamines / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009539:Nicotinic Acids / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013843:Thiazines / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D013950:Thymus Gland / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D008744:Methylamines; D009539:Nicotinic Acids; D013843:Thiazines; D004247:DNA; D010653:Phenylbutazone; D007213:Indomethacin